Screening of Obstructive Sleep Apnea Syndrome in Residents of a Unit of Long-term Care Under Mixed Food
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Enrollment
- 39
- Locations
- 1
- Primary Endpoint
- measure of the index of respiratory events
Study Overview
Brief Summary
Obstructive sleep apnea is a condition that affects 40% to 62% of the population aged over 60 years with major consequences especially on the cardiovascular system.
This syndrome consists of a staff of the pharyngeal muscles. These muscles are also involved in swallowing phenomena and chews, or many elderly patients are subjected to a mixed diet, logically leading to atrophy of the muscles aerodigestive crossroads.
Muscle wasting ENT induced a mixed food could promote collapsibility of VAS, exposing the individual to a higher risk of apnea and hypopnea during sleep.
The objective of this study is to determine if there is a significant increase in the prevalence of obstructive sleep apnea syndrome in the elderly patients residing in long term care units, receiving a mixed food compared to residents in supply to normal texture.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 70 Years to — (Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Resident of a unit of long-term care
- •Recipient or affiliated with Social Security
- •Signature of consent by the patient, guardian or person of trust
- •and mixed food or normal texture food
Exclusion Criteria
- •OSA diagnosed and treated earlier
- •Patients with an abnormal upper airway out edentation
- •Patients unable to give informed consent and having no confidence in individual capacity to do so.
- •Patients with a gastrostomy or jejunostomy
Arms & Interventions
normal texture food
control group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Intervention: various activity scale (IADL) (Other)
normal texture food
control group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Intervention: RU sleeping® (Device)
normal texture food
control group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Intervention: autonomy scale (ADL and AGGIR) (Other)
mixed food
experimental group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Intervention: RU sleeping® (Device)
mixed food
experimental group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Intervention: autonomy scale (ADL and AGGIR) (Other)
mixed food
experimental group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Intervention: various activity scale (IADL) (Other)
Outcomes
Primary Outcomes
measure of the index of respiratory events
Time Frame: up to 24 hours
measured with holter (RU-sleeping®)
Secondary Outcomes
No secondary outcomes reported